ArticleFrontiers in oncology2021

Low-Dose Apatinib Combined With S-1 in Refractory Metastatic Colorectal Cancer: A Phase 2, Multicenter, Single-Arm, Prospective Study.

Ning Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.